Filariasis
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Filariasis Classification and external resources | |
 | |
|---|---|
| ICD-10 | B74. |
| ICD-9 | 125.0-125.9 |
| MeSH | D005368 |
|
WikiDoc Resources for Filariasis | |
|
Articles | |
|---|---|
|
Most recent articles on Filariasis | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Filariasis at Clinical Trials.gov Clinical Trials on Filariasis at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Filariasis
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Filariasis Discussion groups on Filariasis Patient Handouts on Filariasis Directions to Hospitals Treating Filariasis Risk calculators and risk factors for Filariasis
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Filariasis | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Lymphatic Filariasis (Philariasis) is a parasitic and infectious tropical disease, caused by three thread-like parasitic filarial worms called nematode worms, Wuchereria bancrofti, Brugia malayi, and Brugia timori, all transmitted by mosquitoes. It is extremely rare in Western countries. Loa loa is another filarial parasite of humans, transmitted by the deer fly.
Presentation
The most spectacular symptom of lymphatic filariasis is elephantiasis—thickening of the skin and underlying tissues—which was the first disease discovered to be transmitted by insects. Elephantiasis is caused when the parasites lodge in the lymphatic system.
Elephantiasis affects mainly the lower extremities, whereas ears, mucus membranes, and amputation stumps are rarely affected; however, it depends on the species of filaria. W. bancrofti can affect the legs, arms, vulva, breasts, while Brugia timori rarely affects the genitals. Infection by Onchocerca volvulus and the migration of its microfilariae through the cornea is a major cause of blindness (Onchocerciasis). This disease is not known to be fatal, although it can obviously cause a fair amount of pain to the infected.
Incidence/prevalence
Filariasis is endemic in tropical regions of Asia, Africa, Central and South America with 120 million people infected.
In endemic areas of the world (e.g., Malaipea in Indonesia), up to 54% of the population may have microfilariae in their blood.[1]
History
Lymphatic Filariasis is thought to have affected humans since approximately 1500-4000 years ago, though an exact date for its origin is unknown. The first clear reference to the disease occurs in ancient Greek literature, where scholars discuss diagnosis of lymphatic filariasis vs. diagnosis of similar symptoms that can result from leprosy.
The first documentation of symptoms occurred in the 16th century, when Jan Huygen Linschoten wrote about the disease during the exploration of Goa. Soon after, exploration of other parts of Asia and Africa turned up further reports of disease symptoms. It was not until centuries later than an understanding of the disease began to develop.
In 1866, Timothy Lewis, building on the work of Jean-Nicolas Demarquay and Otto Henry Wucherer, made the connection between microfilariae and elephantiasis, establishing the course of research that would ultimately explain the disease. Not long after, in 1876, Joseph Bancroft discovered the adult form of the worm, and finally in 1877 the life cycle involving an arthropod vector was theorized by Patrick Manson, who proceeded to demonstrate the presence of the worms in mosquitoes. Manson incorrectly hypothesized that the disease was transmitted through skin contact with water in which the mosquitoes had laid eggs. In 1900, George Carmichael Low determined the actual transmission method by discovering the presence of the worm in the proboscis of the mosquito vector.[2]
Diagnosis
The diagnosis is made by identifying microfilariae on a Giemsa stained thick blood film. Blood must be drawn at night, since the microfilaria circulate at night, when their vector, the mosquito, is most likely to bite.
There are also PCR assays available for making the diagnosis.
Treatment
Medicines to treat lymphatic filariasis are most effective when used soon after infection, but they do have some toxic side effects. In addition, the disease is difficult to detect early. Therefore, improved treatments and laboratory tests are needed.
Once Filaria is attacked, the patients are likely to get fever once in a year or two with shivering. They are also administered Florocid injections.
Antibiotics as a possible treatment
In 2003 it was suggested that the common antibiotic doxycycline might be effective in treating elephantiasis.[3] The parasites responsible for filariasis have a population of symbiotic bacteria, Wolbachia, that live inside the worm. When the symbiotic bacteria are killed by the antibiotic, the worms themselves also die. Clinical trials in June 2005 by the Liverpool School of Tropical Medicine reported that an 8 week course almost completely eliminated microfilariaemia.[4][5]
- Diethylcarbamazine Citrate (Hetrazan)
The good drugs of choice for killing adult filarial worm are Albendazole (broad spectrum anti-helminthic) and Ivermectin. A combination of DEC & Albendazole or DEC & Ivermectin is found more effective
References
- ↑ Aupali T, Ismid IS, Wibowo H, et al. (2006). "Estimation of the prevalence of lymphatic filariasis by a pool screen PCR assay using blood spots collected on filter paper". Tran R Soc Trop Med Hyg 100 (8): 753–9.
- ↑ Lymphatic Filariasis Discovery. Retrieved on 2008-01-17.
- ↑ Hoerauf A, Mand S, Fischer K, Kruppa T, Marfo-Debrekyei Y, Debrah AY, Pfarr KM, Adjei O, Buttner DW (2003). "Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production". Med Microbiol Immunol (Berl) 192 (4): 211-6. PMID 12684759.
- ↑ Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, Hoerauf A (2005). "Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial". Lancet 365 (9477): 2116-21. PMID 15964448.
- ↑ Outland, Katrina. "New Treatment for Elephantitis: Antibiotics", The Journal of Young Investigators, 2005 Volume 13.
External links
- (2005) "Special issue". Indian Journal of Urology 21 (1).
- BBC News article on Lymphatic filariasis
- Filariasis Research at the University of Tuebingen
ar:فلاريا de:Filarioseit:Filariosi ms:Penyakit Untutnl:Filariasissk:Vlásovce wa:fiyaires
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
